HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eriko Sugano Selected Research

Eriko Sugano Research Topics

Disease

3Retinitis Pigmentosa (Pigmentary Retinopathy)
03/2023 - 11/2009
2Prostatic Neoplasms (Prostate Cancer)
11/2022 - 01/2022
2Alopecia (Baldness)
11/2022 - 01/2022
2Blindness (Hysterical Blindness)
01/2021 - 12/2009
2Ischemia
01/2016 - 01/2003
2Reperfusion Injury
01/2016 - 01/2003
1Atopic Dermatitis (Atopic Eczema)
08/2022
1Macular Degeneration (Age-Related Maculopathy)
01/2021
1Inflammation (Inflammations)
01/2016
1Nervous System Diseases (Neurological Disorders)
11/2015
1Retinal Degeneration
05/2013
1Atrophy
05/2013
1Phototoxic Dermatitis (Phototoxicity)
10/2004
1Infections
10/2004
1Glaucoma
10/2002

Drug/Important Bio-Agent (IBA)

3ChannelrhodopsinsIBA
03/2023 - 12/2009
2Testosterone (Sustanon)FDA Link
11/2022 - 01/2022
1SteroidsIBA
11/2022
1Hormones (Hormone)IBA
11/2022
1Toll-Like Receptor 4IBA
08/2022
1CationsIBA
01/2021
1NucleotidesIBA
01/2021
1AnionsIBA
01/2021
1Transcription Factors (Transcription Factor)IBA
01/2016
1Peptides (Polypeptides)IBA
01/2016
1NF-kappa B (NF-kB)IBA
01/2016
1CalpainIBA
01/2016
1Verteporfin (Visudyne)FDA Link
05/2013
1Retinaldehyde (Retinal)IBA
05/2013
1Rhodopsin (Visual Purple)IBA
11/2009
1Brain-Derived Neurotrophic Factor (BDNF)IBA
10/2004
1Messenger RNA (mRNA)IBA
01/2003
1Carrier Proteins (Binding Protein)IBA
01/2003
1Glutamic Acid (Glutamate)FDA Link
01/2003
1Ophthalmic Solutions (Eye Drops)IBA
10/2002
1nipradilolIBA
10/2002

Therapy/Procedure

2Therapeutics
01/2021 - 11/2015
1Transplantation
10/2004